Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free GEHC Stock Alerts

GE HealthCare Technologies (GEHC) Competitors

GE HealthCare Technologies logo
$62.04 -0.79 (-1.26%)
Closing price 04:00 PM Eastern
Extended Trading
$62.26 +0.23 (+0.36%)
As of 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

GEHC vs. PHG, MDLN, ZBH, SOLV, and SNN

Should you buy GE HealthCare Technologies stock or one of its competitors? MarketBeat compares GE HealthCare Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with GE HealthCare Technologies include Koninklijke Philips (PHG), Medline (MDLN), Zimmer Biomet (ZBH), Solventum (SOLV), and Smith & Nephew SNATS (SNN). These companies are all part of the "medical equipment" industry.

How does GE HealthCare Technologies compare to Koninklijke Philips?

Koninklijke Philips (NYSE:PHG) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and institutional ownership.

GE HealthCare Technologies has a consensus target price of $76.41, suggesting a potential upside of 23.16%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts plainly believe GE HealthCare Technologies is more favorable than Koninklijke Philips.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Koninklijke Philips
1 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.75
GE HealthCare Technologies
0 Sell rating(s)
11 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.48

GE HealthCare Technologies has a net margin of 9.10% compared to Koninklijke Philips' net margin of 5.49%. GE HealthCare Technologies' return on equity of 20.46% beat Koninklijke Philips' return on equity.

Company Net Margins Return on Equity Return on Assets
Koninklijke Philips5.49% 13.51% 5.48%
GE HealthCare Technologies 9.10%20.46%5.73%

13.7% of Koninklijke Philips shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.4% of GE HealthCare Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

GE HealthCare Technologies has higher revenue and earnings than Koninklijke Philips. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Koninklijke Philips$20.17B1.29$1.01B$1.1722.71
GE HealthCare Technologies$20.63B1.37$2.08B$4.1814.84

In the previous week, GE HealthCare Technologies had 11 more articles in the media than Koninklijke Philips. MarketBeat recorded 15 mentions for GE HealthCare Technologies and 4 mentions for Koninklijke Philips. GE HealthCare Technologies' average media sentiment score of 0.87 beat Koninklijke Philips' score of -0.26 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Koninklijke Philips
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
GE HealthCare Technologies
8 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Koninklijke Philips has a beta of 0.75, suggesting that its stock price is 25% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.72, suggesting that its stock price is 28% less volatile than the broader market.

Koninklijke Philips pays an annual dividend of $0.84 per share and has a dividend yield of 3.2%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Koninklijke Philips pays out 71.8% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 3.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has raised its dividend for 1 consecutive years.

Summary

GE HealthCare Technologies beats Koninklijke Philips on 16 of the 19 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Medline?

Medline (NASDAQ:MDLN) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, media sentiment, analyst recommendations and institutional ownership.

82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.8% of Medline shares are owned by company insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

GE HealthCare Technologies has a net margin of 9.10% compared to Medline's net margin of 0.00%. GE HealthCare Technologies' return on equity of 20.46% beat Medline's return on equity.

Company Net Margins Return on Equity Return on Assets
MedlineN/A N/A N/A
GE HealthCare Technologies 9.10%20.46%5.73%

In the previous week, GE HealthCare Technologies had 6 more articles in the media than Medline. MarketBeat recorded 15 mentions for GE HealthCare Technologies and 9 mentions for Medline. Medline's average media sentiment score of 0.95 beat GE HealthCare Technologies' score of 0.87 indicating that Medline is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medline
6 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
GE HealthCare Technologies
8 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Medline currently has a consensus target price of $50.54, suggesting a potential upside of 29.29%. GE HealthCare Technologies has a consensus target price of $76.41, suggesting a potential upside of 23.16%. Given Medline's stronger consensus rating and higher possible upside, equities research analysts plainly believe Medline is more favorable than GE HealthCare Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medline
1 Sell rating(s)
5 Hold rating(s)
22 Buy rating(s)
1 Strong Buy rating(s)
2.79
GE HealthCare Technologies
0 Sell rating(s)
11 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.48

GE HealthCare Technologies has lower revenue, but higher earnings than Medline. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Medline, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medline$29.14B1.76$1.16B$0.32122.16
GE HealthCare Technologies$20.63B1.37$2.08B$4.1814.84

Summary

Medline beats GE HealthCare Technologies on 9 of the 16 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Zimmer Biomet?

Zimmer Biomet (NYSE:ZBH) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

Zimmer Biomet has a beta of 0.46, suggesting that its stock price is 54% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.72, suggesting that its stock price is 28% less volatile than the broader market.

88.9% of Zimmer Biomet shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 1.3% of Zimmer Biomet shares are held by company insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Zimmer Biomet pays an annual dividend of $0.96 per share and has a dividend yield of 1.1%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Zimmer Biomet pays out 24.9% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 3.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has raised its dividend for 1 consecutive years.

GE HealthCare Technologies has a net margin of 9.10% compared to Zimmer Biomet's net margin of 9.05%. GE HealthCare Technologies' return on equity of 20.46% beat Zimmer Biomet's return on equity.

Company Net Margins Return on Equity Return on Assets
Zimmer Biomet9.05% 13.24% 7.28%
GE HealthCare Technologies 9.10%20.46%5.73%

GE HealthCare Technologies has higher revenue and earnings than Zimmer Biomet. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Zimmer Biomet$8.41B2.05$705.20M$3.8523.10
GE HealthCare Technologies$20.63B1.37$2.08B$4.1814.84

Zimmer Biomet currently has a consensus price target of $100.70, suggesting a potential upside of 13.23%. GE HealthCare Technologies has a consensus price target of $76.41, suggesting a potential upside of 23.16%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts plainly believe GE HealthCare Technologies is more favorable than Zimmer Biomet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zimmer Biomet
3 Sell rating(s)
13 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.25
GE HealthCare Technologies
0 Sell rating(s)
11 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.48

In the previous week, GE HealthCare Technologies had 4 more articles in the media than Zimmer Biomet. MarketBeat recorded 15 mentions for GE HealthCare Technologies and 11 mentions for Zimmer Biomet. GE HealthCare Technologies' average media sentiment score of 0.87 beat Zimmer Biomet's score of 0.79 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Zimmer Biomet
7 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
GE HealthCare Technologies
8 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

GE HealthCare Technologies beats Zimmer Biomet on 13 of the 20 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Solventum?

GE HealthCare Technologies (NASDAQ:GEHC) and Solventum (NYSE:SOLV) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation and media sentiment.

In the previous week, GE HealthCare Technologies had 9 more articles in the media than Solventum. MarketBeat recorded 15 mentions for GE HealthCare Technologies and 6 mentions for Solventum. GE HealthCare Technologies' average media sentiment score of 0.87 beat Solventum's score of 0.74 indicating that GE HealthCare Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GE HealthCare Technologies
8 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Solventum
3 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

GE HealthCare Technologies has a beta of 0.72, indicating that its stock price is 28% less volatile than the broader market. Comparatively, Solventum has a beta of 0.66, indicating that its stock price is 34% less volatile than the broader market.

GE HealthCare Technologies has higher revenue and earnings than Solventum. Solventum is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GE HealthCare Technologies$20.63B1.37$2.08B$4.1814.84
Solventum$8.33B1.64$1.56B$8.169.64

82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.4% of GE HealthCare Technologies shares are owned by insiders. Comparatively, 0.2% of Solventum shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

GE HealthCare Technologies currently has a consensus target price of $76.41, indicating a potential upside of 23.16%. Solventum has a consensus target price of $81.91, indicating a potential upside of 4.14%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts clearly believe GE HealthCare Technologies is more favorable than Solventum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GE HealthCare Technologies
0 Sell rating(s)
11 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.48
Solventum
1 Sell rating(s)
6 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.38

Solventum has a net margin of 17.33% compared to GE HealthCare Technologies' net margin of 9.10%. Solventum's return on equity of 23.51% beat GE HealthCare Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
GE HealthCare Technologies9.10% 20.46% 5.73%
Solventum 17.33%23.51%7.63%

Summary

GE HealthCare Technologies beats Solventum on 11 of the 16 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Smith & Nephew SNATS?

GE HealthCare Technologies (NASDAQ:GEHC) and Smith & Nephew SNATS (NYSE:SNN) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, earnings, dividends and valuation.

GE HealthCare Technologies has higher revenue and earnings than Smith & Nephew SNATS.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GE HealthCare Technologies$20.63B1.37$2.08B$4.1814.84
Smith & Nephew SNATS$6.16B2.07$625MN/AN/A

GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Smith & Nephew SNATS pays an annual dividend of $0.93 per share and has a dividend yield of 3.1%. GE HealthCare Technologies pays out 3.3% of its earnings in the form of a dividend. GE HealthCare Technologies has increased its dividend for 1 consecutive years.

82.1% of GE HealthCare Technologies shares are owned by institutional investors. Comparatively, 25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 0.4% of GE HealthCare Technologies shares are owned by insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

GE HealthCare Technologies has a net margin of 9.10% compared to Smith & Nephew SNATS's net margin of 0.00%. GE HealthCare Technologies' return on equity of 20.46% beat Smith & Nephew SNATS's return on equity.

Company Net Margins Return on Equity Return on Assets
GE HealthCare Technologies9.10% 20.46% 5.73%
Smith & Nephew SNATS N/A N/A N/A

In the previous week, GE HealthCare Technologies had 14 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 15 mentions for GE HealthCare Technologies and 1 mentions for Smith & Nephew SNATS. Smith & Nephew SNATS's average media sentiment score of 1.13 beat GE HealthCare Technologies' score of 0.87 indicating that Smith & Nephew SNATS is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GE HealthCare Technologies
8 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Smith & Nephew SNATS
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

GE HealthCare Technologies has a beta of 0.72, indicating that its stock price is 28% less volatile than the broader market. Comparatively, Smith & Nephew SNATS has a beta of 0.56, indicating that its stock price is 44% less volatile than the broader market.

GE HealthCare Technologies presently has a consensus price target of $76.41, indicating a potential upside of 23.16%. Smith & Nephew SNATS has a consensus price target of $30.93, indicating a potential upside of 2.55%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, equities analysts plainly believe GE HealthCare Technologies is more favorable than Smith & Nephew SNATS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GE HealthCare Technologies
0 Sell rating(s)
11 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.48
Smith & Nephew SNATS
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.17

Summary

GE HealthCare Technologies beats Smith & Nephew SNATS on 12 of the 17 factors compared between the two stocks.

Get GE HealthCare Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for GEHC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GEHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GEHC vs. The Competition

Export
MetricGE HealthCare TechnologiesMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$28.22B$8.55B$6.82B$12.42B
Dividend Yield0.22%2.48%2.67%9.39%
P/E Ratio14.8415.3927.0024.20
Price / Sales1.376.82519.3894.43
Price / Cash10.7318.5526.6847.25
Price / Book2.723.2510.676.26
Net Income$2.08B$230.22M$3.60B$331.76M
7 Day Performance0.62%-1.47%-0.32%-1.10%
1 Month Performance0.73%-1.70%1.88%-1.26%
1 Year Performance-16.34%-0.69%25.50%18.84%

GE HealthCare Technologies Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GEHC
GE HealthCare Technologies
4.9667 of 5 stars		$62.04
-1.3%		$76.41
+23.2%		-17.3%$28.22B$20.63B14.8454,000
PHG
Koninklijke Philips
2.2324 of 5 stars		$27.34
-0.2%		N/A+8.9%$26.93B$20.17B23.4265,340
MDLN
Medline
4.3533 of 5 stars		$40.58
-1.1%		$50.54
+24.5%		N/A$53.91B$28.43B126.8145,000
ZBH
Zimmer Biomet
3.7802 of 5 stars		$94.09
+3.0%		$102.33
+8.8%		-3.7%$17.67B$8.23B24.4417,000
SOLV
Solventum
3.5192 of 5 stars		$77.48
+1.0%		$83.67
+8.0%		+8.1%$13.28B$8.33B9.5020,000

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:GEHC) was last updated on 7/21/2026 by MarketBeat.com Staff.
From Our Partners
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Oil is settling in yuan now - here's what that means for gold
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel